WPC
CORT icon

Wedmont Private Capital’s Corcept Therapeutics CORT Stock Holding History

Wedmont Private Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
+3,139
New +$190K 0.01% 751
2025
Q4 		– Sell
-2,644
Closed -$239K – 812
2025
Q3 		$239K Buy
+2,644
New +$191K 0.01% 690

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Wedmont Private Capital's CORT Position: Q2 2026 in Review

Wedmont Private Capital opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,139 shares worth $288K. The stake represents 0.01% of the portfolio and ranks #751 among its holdings. This is a return to the name: Wedmont Private Capital previously reported a position in CORT as recently as Q3 2025.

Wedmont Private Capital first reported a position in CORT in Q3 2025 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Wedmont Private Capital held 3,139 shares of Corcept Therapeutics worth $288K as of Q2 2026.
  • Corcept Therapeutics was a new Wedmont Private Capital position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #751 holding.
  • Wedmont Private Capital first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.